Both in Pharmaceuticals
Skye Bioscience vs Pulmatrix
Over the past year SKYE returned −89.6% and PULM returned −71.0%; their daily moves had a correlation of 0.00.
SKYE −89.6% PULM −71.0%Growth of $1, one year, split-adjusted
| Metric | SKYE | PULM |
|---|---|---|
| Price | $1.31 | $1.42 |
| Market cap | $5.8M | $5.2M |
| Today | −13.82% | −5.67% |
| 1 month | −18.6% | −6.9% |
| 6 months | −81.4% | +12.3% |
| Year to date | −78.2% | −36.5% |
| 1 year | −89.5% | — |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $9.9M | $2.2M |
| Dividend yield | — | — |
| Volatility (60d) | 617.6% | 63.9% |
| Short % of float | 0.6% | 1.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).